New Describe a product, get the CN code. Also as API and MCP for AI agents. Try it free
Jump to content

Tariff number 3001000000 80 - Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included

Email me changes

Import trade restrictions for 3001000000 80

This table contains information on trade restrictions for the import of goods into the EU and the EU into third countries. The table contains information on trade restrictions which are imposed due to customs unions, preferences, tariff quotas, customs unions, veterinary controls, third country duties and non-preferential tariff quotas.

Duties 22
1011
ERGA OMNES 1011
01-01-2002
0 %
Third country duty 103
FO
Faroe Islands FO
01-01-1997
0 %
Tariff preference 142
XL
Melilla XL
01-01-1999
0 %
Accession act0001/85
Tariff preference 142
SM
San Marino SM
01-01-2006
0 %
Customs union duty 106
TR
Türkiye TR
01-01-2006
0 %
Customs union duty 106
AD
Andorra AD
01-01-2006
0 %
Customs union duty 106
1007
EU-Switzerland agreement: re-imported goods 1007
01-01-2007
0 %
Tariff preference 142
GB
United Kingdom GB
01-01-2021
0 %
Tariff preference 142
2080
OCTs (Overseas Countries and Territories) 2080
01-01-2021
0 %
Tariff preference 142
TN
Tunisia TN
01-03-1998
0 %
Tariff preference 142
MA
Morocco MA
01-03-2000
0 %
Tariff preference 142
LB
Lebanon LB
01-04-2006
0 %
Tariff preference 142
JO
Jordan JO
01-05-2002
0 %
Tariff preference 142
XC
Ceuta XC
01-07-1991
0 %
Accession act0001/85
Tariff preference 142
US
United States US
01-07-2026
0 %
Tariff preference 142
SY
Syria SY
01-08-1994
0 %
Tariff preference 142
DZ
Algeria DZ
01-09-2005
0 %
Tariff preference 142
1011
ERGA OMNES 1011
01-11-2026
2 EUR
Union handling fee 800
1011
ERGA OMNES 1011
01-11-2026
3 EUR
Low-value consignment customs duty 107
2000
Preferential origin in accordance with the Agreement in the form of an Exchange of Letters between the European Union and the Kingdom of Morocco on the amendment of Protocols 1 and 4 to the Euro-Mediterranean Agreement establishing an association between the European Communities and their Member States, of the one part, and the Kingdom of Morocco, of the other part. 2000
03-10-2025
0 %
Tariff preference 142
IL
Israel IL
16-05-2023
0 %
Tariff preference 142
CH
Switzerland CH
25-10-2000
0 %
Tariff preference 142
Controls and documents 3
1011
ERGA OMNES 1011
10-02-2023
Document required
banned without it
Import control on REACH 761
UA
Ukraine UA
24-06-2026
Document required
banned without it
Import control 762
UA
Ukraine UA
24-06-2026
Document required
banned without it
Import control 760

Explanation of trade restrictions

Erga Omnes means "for all".

Third countries are countries that are not part of the EU.

GSP means "Generalised System of Preferences".

GSP Plus means "Generalised System of Preferences Plus".

European Economic Area (EEA) means all EU member states and Iceland, Liechtenstein and Norway.

OCTs stands for "Overseas Countries and Territories". They are countries and territories that are not part of the EU. More information

CARIFORUM is a regional economic integration organisation comprising 15 Caribbean Community (CARICOM) countries and the Dominican Republic.

SADC EPA stands for "Southern African Development Community - Economic Partnership Agreement".

Duty means "customs duties".

Estimate the import cost for 3001000000

  • Customs value €1,000.00
  • Customs duty 0 % €0.00
  • Import VAT 19 % €190.00
  • Total €1,190.00

Documents and checks for China

  • Import control on REACH: Document required, banned without it Y106Y110Y113

An estimate only. The customs value is the price including transport and insurance to the EU border. Excise duties, other fees and producer-specific anti-dumping rates are not included. Preferential rates need valid proof of origin. Country groups and exclusions: TARIC, as of November 2026.

History

Duty rates and measures for this code over time (yearly snapshots).

Preferential rules of origin for 3001000000

What the goods must meet to count as originating in a partner country and get the preferential duty, per agreement.

  • Autonomous Trade Preferences (Western Balkans) · Kosovo

    EU-Chile Association Agreement · Chile

    EU-Algeria Association Agreement · Algeria

    EU-Egypt Association Agreement · Egypt

    EU-Jordan Association Agreement · Jordan

    EU-Lebanon Association Agreement · Lebanon

    EU-Morocco Association Agreement · Morocco

    EU-Tunisia Association Agreement · Tunisia

    Pharmaceutical products; except for: / or: Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  • EPA CARIFORUM

    EU Market Access Regulation (EPA) · Cameroon, Côte d’Ivoire, Ghana, Kenya

    EU-Mexico Global Agreement · Mexico

    Pharmaceutical products; except for: / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials classified within the same heading may be used provided their value does not exceed 20 % of the ex-works price of the product

  • Generalised Scheme of Preferences (GSP, GSP+, EBA) · Armenia, India, Kenya, Pakistan, Samoa, Solomon Islands, Syria, Vietnam

    EU-Singapore FTA · Singapore

    Pharmaceutical products / or: Manufacture from materials of any heading

  • EU-Colombia/Peru/Ecuador Trade Agreement · Colombia, Ecuador, Peru

    Pharmaceutical products; except for: / or: Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

  • EU-Japan EPA · Japan

    CTSH; A chemical reaction, purification, mixing and blending, production of standard materials, a change in particle size, isomer separation or biotechnological processing is undergone; MaxNOM 50 % (EXW); or RVC 55 % (FOB).

  • EU-Korea FTA · South Korea

    Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included. / or: Manufacture from materials of any heading

  • EU-Central America Association Agreement

    Glands and other organs for organo therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included / or: Manufacture from materials of any heading

  • EU-Palestine Interim Association Agreement · Palestine

    Pharmaceutical products; except for: / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials classified within the same heading may be used provided their value does not exceed 20% of the ex-works price of the product

  • EU-Viet Nam FTA · Vietnam

    Pharmaceutical products. / or: Manufacture from materials of any heading.

Source: European Commission, Access2Markets (CC BY 4.0, shortened). The text of the agreement prevails. Access2Markets

Legal and explanatory notes for 3001000000

3001 20 90 CN Explanatory Notes: Other

This subheading includes intrinsic factor (dried purified extracts of pyloric mucous membrane of swine).

3001 90 91 CN Explanatory Notes: Heparin and its salts

See the HS Explanatory Note to heading 3001, (C).

3001 90 20 - 3001 90 98 CN Explanatory Notes: to 3001 90 98

Other In addition to the glands and other organs mentioned in the HS Explanatory Note to heading 3001, (A), these subheadings include the hypophysis, the suprarenal capsules and the thyroid gland.

Notes to chapter 30

Notes 1. This chapter does not cover: (a) foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); (b) products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 2404); (c) plasters specially calcined or finely ground for use in dentistry (heading 2520); (d) aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading 3301); (e) preparations of headings 3303 to 3307, even if they have therapeutic or prophylactic properties; (f) soap or other products of heading 3401 containing added medicaments; (g) preparations with a basis of plaster for use in dentistry (heading 3407); (h) blood albumin not prepared for therapeutic or prophylactic uses (heading 3502); or (ij) diagnostic reagents of heading 3822. 2. For the purposes of heading 3002, the expression ‘immunological products’ applies to peptides and proteins (other than goods of heading 2937) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumour-necrosis factors (TNF), growth factors (GF), hematopoietins and colony-stimulating factors (CSF). 3. For the purposes of headings 3003 and 3004 and of note 4(d) to this chapter, the following are to be treated: (a) as unmixed products: (1) unmixed products dissolved in water; (2) all goods of Chapter 28 or 29; and (3) simple vegetable extracts of heading 1302, merely standardised or dissolved in any solvent; (b) as products which have been mixed: (1) colloidal solutions and suspensions (other than colloidal sulphur); (2) vegetable extracts obtained by the treatment of mixtures of vegetable materials; and (3) salts and concentrates obtained by evaporating natural mineral waters. 4. Heading 3006 applies only to the following, which are to be classified in that heading and in no other heading of the nomenclature: (a) sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; (b) sterile laminaria and sterile laminaria tents; (c) sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable; (d) opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two or more ingredients which have been mixed together for such uses; (e) placebos and blinded (or double-blinded) clinical trial kits for use in recognised clinical trials, put up in measured doses, even if they might contain active medicaments; (f) dental cements and other dental fillings; bone reconstruction cements; (g) first-aid boxes and kits; (h) chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides; (ij) gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; (k) waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life; and (l) appliances identifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates. Subheading notes 1. For the purposes of subheadings 3002 13 and 3002 14, the following are to be treated: (a) as unmixed products, pure products, whether or not containing impurities; (b) as products which have been mixed: (1) the products mentioned in (a) above dissolved in water or in other solvents; (2) the products mentioned in (a) and (b) (1) above with an added stabiliser necessary for their preservation or transport; and (3) The products mentioned in (a), (b) (1) and (b) (2) above with any other additive. 2. Subheadings 3003 60 and 3004 60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients : amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN). Additional note 1. Heading 3004 includes herbal medicinal preparations and preparations based on the following active substances: vitamins, minerals, essential amino-acids or fatty acids, in packings for retail sale. These preparations are classified in heading 3004 if they bear on the label, packaging or on the accompanying user directions the following statements of: (a) the specific diseases, ailments or their symptoms for which the product is to be used; (b) the concentration of active substance or substances contained therein; (c) dosage; and (d) mode of application. This heading includes homeopathic medicinal preparations when they meet the conditions of (a), (c) and (d) mentioned above. In the case of preparations based on vitamins, minerals, essential amino-acids or fatty acids, the level of one of these substances per recommended daily dose indicated on the label must be significantly higher than the recommended daily allowance to maintain general health or well-being.

Other explanatory notes for the chapter

Additional note 1 1. Herbal medicinal preparations are preparations based on one or more active substances, produced by subjecting a plant or parts thereof to a process such as drying, crushing, extraction or purification. Active substance means a chemically defined substance, a chemically defined group of substances (for example, alkaloids, polyphenols, anthocyanins) or a plant extract. These active substances must have medicinal properties for the prevention or the treatment of specific diseases, ailments or their symptoms. 2. Homeopathic medicinal preparations are prepared from products, substances or compositions called homeopathic stocks (mother tinctures). The degree of dilution must be indicated (for example, D6). 3. Vitamins or mineral preparations are preparations based on vitamins of heading 2936, on minerals including trace elements and mixtures thereof. They are used to treat or prevent specific diseases, ailments or their symptoms. Such preparations contain a much higher amount of vitamins or minerals, generally at least three times higher than the recommended daily allowance (RDA). As regards the recommended daily allowance (RDA) for certain vitamins and minerals, see, for example, the table in the Annex XIII to Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers (OJ L 304, 22.11.2011, p. 58) reproduced below: Vitamins and minerals | RDA Vitamin A | 800 μg Vitamin D | 5 μg Vitamin E | 12 mg Vitamin K | 75 μg Vitamin C | 80 mg Thiamin 1,1 mg Riboflavin | 1,4 mg Niacin 16 mg Vitamin B6 | 1,4 mg Folic acid | 200 μg Vitamin B12 | 2,5 μg Biotin 50 μg Pantothenic acid | 6 mg Potassium | 2 000 mg Chloride 800 mg Calcium 800 mg Phosphorus | 700 mg Magnesium | 375 mg Iron 14 mg Zinc 10 mg Copper 1 mg Manganese | 2 mg Fluoride 3,5 mg Selenium 55 μg Chromium 40 μg Molybdenum | 50 μg Iodine 150 μg 4. Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential amino acids, according to the joint WHO/FAO/UNU expert Consultation 2007: Essential Amino Acid | RDA (mg) Histidine | 700 Isoleucine | 1 400 Leucine 2 730 Lysine 2 100 Methionine + Cysteine | 1 050 Cysteine 287 Methionine | 728 Phenylalanine + Tyrosine | 1 750 Threonine | 1 050 Tryptophan | 280 Valine 1 820 Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential fatty acids, according to the joint WHO/FAO/UNU expert Consultation 2007. Types of essential fatty acids | Name of essential fatty acid | RDA (g) n-3 polyunsaturated fatty acids | linolenic acid (ALA) | 2 long-chain n-3 polyunsaturated fatty acids | EPA plus DHA | 0,25 n-6 polyunsaturated fatty acids | linoleic acid | 10

Sources: Combined Nomenclature 2026, Annex I to Regulation (EEC) No 2658/87 (CELEX 32025R1926), and the Explanatory Notes to the Combined Nomenclature (CELEX 02019XC0329(02)-20260213). The section and chapter notes are legally binding; the explanatory notes are guidance. EUR-Lex

EU classification regulations for 3001000000

Commission regulations that classified specific goods under this code. They bind customs in every member state for identical goods.

  • 3001 20 90 Jul 12, 1991 · Regulation on EUR-Lex
    Ox-bile extract, obtained by purifying the liquid bile with ethanol and animal black (to deodorize and remove colour) and evaporating to dryness

    This product is used therapeutically

    Reasons

    Classfication is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and by the wording of CN codes 3001, 3001 20 and 3001 20 90. Having been treated in a way disallowed to products of heading 0510 and being used (directly) in therapy, products of this type must be classified under heading 3001 (see also explanatory notes to the HS, heading 30.01, letter B).

UK advance tariff rulings for 3001000000

Rulings of HM Revenue & Customs for goods with UK commodity codes that start like this EU code. The UK tariff differs from the EU tariff, so these rulings are guidance for the EU.

  • UK 3001902000 Valid Dec 21, 2023 to Dec 20, 2026 · Ruling 600009447 on GOV.UK

    Human resected Tumour Material submerged in Phosphate Buffered Saline with Antibiotics. This is to be used as starting material in an autologous therapy.

    Justification

    Classification has been determined in accordance with the following: For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)) Classification has been determined in accordance with the following: General Interpretative Rules (GIR)s: GIR 1 has been used to classify this product by the terms of heading 3001: Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for or-gano-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not else-where specified or included GIR 6 Has been used to classify this product by the terms of heading 300190: Other than extracts of glands or other organs or of their secretions 8 Digit code 30019020: …

  • UK 3001902000 Valid Mar 19, 2025 to Mar 18, 2028 · Ruling 600012429 on GOV.UK

    Human tissue, The samples are of human tissue biological substances, being utilised for diagnostic testing and laboratory research as part of therapeutic clinical trials. It is important to note that human tissue samples are handled following stringent ethical and regulatory guidelines to maintain patient confidentiality and consent. Additionally, these samples are often subject to rigorous quality control measures to ensure their suitability for research and diagnostic purposes. These samples are meticulously packaged in collection tubes, slides, or blocks to ensure their integrity and viability for accurate analysis.

    Justification

    Classification has been determined in accordance with the following: For the purposes of determining the commodity codes within which goods most appropriately fall, Reg 3(1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s: GIR 1 has been used to classify this product by the terms of heading 3001: Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not else-where specified or included. GIR 6 Has been used to classify this product by the terms of heading 300190: Other than extracts of glands or other organs or of their secretions. 8 Digit code 30019020: Of human origin. Also classified in accordance with: …

Source: HM Revenue & Customs, Advance Tariff Rulings. Contains public sector information licensed under the Open Government Licence v3.0.

Import VAT in the EU

  • Austria 20 %
  • Belgium 21 %
  • Bulgaria 20 %
  • Croatia 25 %
  • Cyprus 19 % maybe 5 %
  • Czechia 21 % maybe 12 %
  • Denmark 25 %
  • Estonia 24 %
  • Finland 25.5 % maybe 13.5 %
  • France 20 %
  • Germany 19 %
  • Greece 24 % maybe 13 %
  • Hungary 27 %
  • Ireland 23 %
  • Italy 22 %
  • Latvia 21 % maybe 12 %
  • Lithuania 21 % maybe 5 %
  • Luxembourg 17 %
  • Malta 18 % maybe 5 %
  • Netherlands 21 %
  • Poland 23 %
  • Portugal 23 %
  • Romania 21 %
  • Slovakia 23 % maybe 5 %
  • Slovenia 22 %
  • Spain 21 %
  • Sweden 25 %

Standard rate per member state, on the customs value, the duty and transport to the destination. Reduced rates often depend on the use or the buyer and apply only where the country provides them for these goods. Source: European Commission, Taxes in Europe Database, as of Nov 2, 2026.

Rules of origin

Preferential rules of origin for subheading 300100 depend on the trade agreement. The Commission publishes them in Access2Markets.

Rules of origin on Access2Markets

Information

When importing or exporting "Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included", it is crucial to have the correct HS code or TARIC code. The HS code 3001000000 80 serves as the standard code for this product, ensuring that the appropriate duties and taxes are applied when crossing international borders.

To ensure your business transactions run smoothly when importing or exporting "Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included", consider the following points:

  1. Inform yourself about the specific import and export regulations in the countries involved. This includes possible restrictions, taxes, and duties applicable to "Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included".
  2. Check if any additional licenses, permits, or certificates are required to import "Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included" into the destination country or export it from the country of origin.
  3. Make sure your trading partners have valid identification numbers, such as EORI numbers (Economic Operators Registration and Identification) in the EU, to streamline trade and minimize delays.
  4. Ensure that all trade- and customs-related documents (such as commercial invoices, packing lists, certificates of origin, and insurance policies) are accurately completed and adhere to the respective national regulations.
  5. Keep an eye on the current exchange rates, as well as packaging, shipping, and insurance costs, to accurately calculate trade costs.

In summary, the HS code or TARIC code for "Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included" is 3001000000 80. Make sure you accurately use this code in all your trade and customs documents to guarantee smooth and hassle-free transactions. With these tips, you'll be better prepared for the challenges of international trade and can successfully import and export "Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included".

HS Code structure

30
Chapter
01
Heading
00
Subheading
00
CN Subheading
00
TARIC Subheading
80
Additional TARIC codes

1. Chapter

There are 21 different sections, which are divided into 96 chapters. Exceptional chapters include chapter 77, which is reserved for future use, chapters 98 and 99, which are limited at national level, and chapter 99, which is a specific code for temporary changes. In the example above, chapter 30 was selected for pharmaceutical products

2. Heading

The heading determines the specific category within a certain chapter. In the example above, the 01 refers to Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included.

HS Code tree structure

3000000000 80

Chapter PHARMACEUTICAL PRODUCTS

3001000000 80

Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included

3001200000 80

- Extracts of glands or other organs or of their secretions

3001201000 80

- - Of human origin

3001209000 80

- - Other

3001900000 80

- Other

3001902000 80

- - Of human origin

3001909100 10

- - Other

3001909100 80

- - - Heparin and its salts

3001909800 80

- - - Other